The U.S. is considering adopting a new childhood vaccine schedule similar to Denmark's, potentially exposing vaccine manufacturers to lawsuits. This change could jeopardize the legal protections these manufacturers have enjoyed for decades. The Department of Health and Human Services is leading the effort and the final decision will be postponed until the new year. Anti-vaccine activists believe the change could undermine those protections by making certain vaccines "non-routine." This could lead to manufacturers losing their federal liability shield. Legal experts disagree with this assessment, though it hinges on how "routine recommendation" is legally interpreted. Adopting a different schedule could also decrease the number of children receiving certain vaccines and increase the prevalence of related diseases. The potential loss of legal protection could discourage vaccine makers and impact vaccine availability. This is a complex situation with significant implications for vaccine access and public health. This decision is also tied to Trump's directive to align U.S. vaccine recommendations with those of other developed countries. The situation could also create a pre-1986 challenge where courts could be flooded.
axios.com
axios.com
Create attached notes ...
